Disease-modifying drugs for systemic sclerosis: why have we not found them yet?
作者信息
Derk Chris T
出版信息
Expert Rev Clin Immunol. 2011 Jul;7(4):399-401. doi: 10.1586/eci.11.29.
PMID:21790280
Abstract
摘要
相似文献
1
Disease-modifying drugs for systemic sclerosis: why have we not found them yet?系统性硬化症的疾病修饰药物：为何我们尚未找到它们？
Expert Rev Clin Immunol. 2011 Jul;7(4):399-401. doi: 10.1586/eci.11.29.
2
[Rheumatology--a glimpse of a rapidly developing discipline].[风湿病学——快速发展学科的一瞥]
Ugeskr Laeger. 2012 Mar 19;174(12):804.
3
Severe polymyositis and flare in autoimmunity following treatment with adalimumab in a patient with overlapping features of polyarthritis and scleroderma.一名具有多关节炎和硬皮病重叠特征的患者在使用阿达木单抗治疗后出现严重多发性肌炎和自身免疫性发作。
Scand J Rheumatol. 2007 Nov-Dec;36(6):484-6. doi: 10.1080/03009740701281293.
4
Rheumatoid arthritis interstitial lung disease: mycophenolate mofetil as an antifibrotic and disease-modifying antirheumatic drug.类风湿关节炎间质性肺病：霉酚酸酯作为一种抗纤维化和改善病情的抗风湿药物。
Arch Intern Med. 2008 Aug 11;168(15):1718-9. doi: 10.1001/archinte.168.15.1718.
5
Effectiveness of biologic therapies for rheumatoid arthritis: an indirect comparisons approach.生物制剂治疗类风湿关节炎的疗效：间接比较法。
Pharmacotherapy. 2011 Jan;31(1):39-51. doi: 10.1592/phco.31.1.39.
6
Disease-modifying antirheumatic drugs: enhancing efficacy by combination.改善病情抗风湿药：联合用药提高疗效
Lancet. 2004 Feb 28;363(9410):670-1. doi: 10.1016/S0140-6736(04)15660-2.
7
[Rheumatology 2010].[《风湿病学》2010年]
Dtsch Med Wochenschr. 2010 Jun;135(25-26):1309-11. doi: 10.1055/s-0030-1255160. Epub 2010 Jun 16.
8
New drugs for rheumatoid arthritis.治疗类风湿性关节炎的新药。
N Engl J Med. 2004 Aug 26;351(9):937-8. doi: 10.1056/NEJM200408263510922.
9
Systemic sclerosis: hypothesis-driven treatment strategies.系统性硬化症：基于假设的治疗策略。
Lancet. 2006 May 20;367(9523):1683-91. doi: 10.1016/S0140-6736(06)68737-0.
10
Rituximab (Rituxan) for rheumatoid arthritis.利妥昔单抗（美罗华）用于治疗类风湿性关节炎。
Med Lett Drugs Ther. 2006 Apr 24;48(1233):34-5.
引用本文的文献
1
Personalized medicine in systemic sclerosis: facts and promises.系统性硬皮病的个体化医学：现状与展望。
Curr Rheumatol Rep. 2014 Jun;16(6):425. doi: 10.1007/s11926-014-0425-8.
2
Disease modification in systemic sclerosis. Do integrated approaches offer new challenges?系统性硬化症的疾病修饰。综合方法会带来新的挑战吗？
Z Rheumatol. 2013 May;72(4):326-8. doi: 10.1007/s00393-013-1157-2.
3
Update on management of connective tissue panniculitides.结缔组织性脂膜炎治疗进展。
Dermatol Ther. 2012 Mar-Apr;25(2):173-82. doi: 10.1111/j.1529-8019.2012.01489.x.
Zotero 插件